Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
20.03
20.03
20.03
20.03
20.03
20.00
Share Warrants & Outstandings
Total Reserve
651.64
572.81
482.44
412.85
346.36
293.09
Shareholder's Funds
671.67
592.84
502.47
432.88
366.39
313.09
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.38
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.14
1.24
Secured Loans
0.00
0.00
0.00
0.00
0.14
1.24
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
13.00
11.46
7.94
6.45
5.69
5.43
Other Long Term Liabilities
5.39
3.62
4.72
4.54
4.29
4.05
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.73
0.10
0.14
0.00
0.00
0.00
Total Non-Current Liabilities
19.12
15.18
12.80
10.99
10.13
10.33
Current Liabilities
Trade Payables
84.95
72.44
50.87
71.67
57.07
51.24
Other Current Liabilities
14.78
15.25
15.39
14.12
16.22
10.06
Short Term Borrowings
0.00
1.07
2.00
2.04
0.38
3.83
Short Term Provisions
6.49
3.52
3.89
2.66
2.18
0.44
Total Current Liabilities
106.22
92.28
72.15
90.49
75.84
65.58
Total Liabilities
797.01
700.29
587.42
534.36
452.36
389.39
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
251.66
236.33
197.16
170.75
141.58
146.38
Less: Accumulated Depreciation
69.88
57.21
46.86
39.12
31.22
23.95
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
181.78
179.12
150.30
131.63
110.36
122.42
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
4.47
3.48
6.71
16.05
1.69
0.04
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.09
Long Term Loans & Advances
110.22
79.58
62.49
31.83
30.83
18.51
Other Non Current Assets
0.41
0.12
0.47
1.75
0.45
0.03
Total Non-Current Assets
297.07
262.51
220.21
181.51
143.61
141.39
Current Assets Loans & Advances
Current Investments
173.72
138.92
91.33
96.81
80.66
34.22
Inventories
78.68
77.17
70.03
72.74
46.61
47.40
Sundry Debtors
166.40
161.77
136.33
115.94
113.35
101.34
Cash and Bank
22.43
13.83
34.32
18.80
13.84
14.58
Other Current Assets
3.15
1.62
1.96
0.53
1.22
1.09
Short Term Loans and Advances
55.57
44.47
33.25
48.03
53.06
49.38
Total Current Assets
499.94
437.78
367.21
352.85
308.75
248.00
Net Current Assets (Including Current Investments)
393.72
345.50
295.07
262.36
232.91
182.41
Total Current Assets Excluding Current Investments
326.22
298.87
275.89
256.04
228.09
213.78
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
797.01
700.29
587.42
534.36
452.36
389.39
Contingent Liabilities
3.12
0.23
0.23
0.23
2.30
2.19
Total Debt
0.00
1.07
2.00
2.04
0.52
4.68
Book Value per share (adjusted)
335.34
295.98
250.86
216.12
182.92
156.54
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -100.00% vs -46.50% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 48.90% vs -23.31% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 2.00% vs 16.30% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 14.20% vs 19.22% in Mar 2024
Compare Balance Sheet Results of Lincoln Pharma.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
20.03
13.37
6.66
49.81%
Share Warrants & Outstandings
Total Reserve
651.64
547.58
104.06
19.00%
Shareholder's Funds
671.67
560.95
110.72
19.74%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
13.00
15.58
-2.58
-16.56%
Other Long Term Liabilities
5.39
0.00
5.39
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.73
2.90
-2.17
-74.83%
Total Non-Current Liabilities
19.12
18.48
0.64
3.46%
Current Liabilities
Trade Payables
84.95
91.86
-6.91
-7.52%
Other Current Liabilities
14.78
36.65
-21.87
-59.67%
Short Term Borrowings
0.00
1.69
-1.69
-100.00%
Short Term Provisions
6.49
6.08
0.41
6.74%
Total Current Liabilities
106.22
136.29
-30.07
-22.06%
Total Liabilities
797.01
715.72
81.29
11.36%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
251.66
633.87
-382.21
-60.30%
Less: Accumulated Depreciation
69.88
404.45
-334.57
-82.72%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
181.78
229.42
-47.64
-20.77%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
4.47
26.39
-21.92
-83.06%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.02
-0.02
-100.00%
Long Term Loans & Advances
110.22
4.97
105.25
2,117.71%
Other Non Current Assets
0.41
3.21
-2.80
-87.23%
Total Non-Current Assets
297.07
264.00
33.07
12.53%
Current Assets Loans & Advances
Current Investments
173.72
84.09
89.63
106.59%
Inventories
78.68
100.49
-21.81
-21.70%
Sundry Debtors
166.40
112.22
54.18
48.28%
Cash and Bank
22.43
80.10
-57.67
-72.00%
Other Current Assets
3.15
12.59
-9.44
-74.98%
Short Term Loans and Advances
55.57
62.22
-6.65
-10.69%
Total Current Assets
499.94
451.72
48.22
10.67%
Net Current Assets (Including Current Investments)
393.72
315.43
78.29
24.82%
Total Current Assets Excluding Current Investments
326.22
367.63
-41.41
-11.26%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
797.01
715.72
81.29
11.36%
Contingent Liabilities
3.12
38.20
-35.08
-91.83%
Total Debt
0.00
1.69
-1.69
-100.00%
Book Value per share (adjusted)
335.34
419.65
-84.31
-20.09%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs -46.50% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 5.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 48.90% vs -23.31% in Mar 2024
Annual - Fixed Assets
Fixed Assets 186.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.00% vs 16.30% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 499.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.20% vs 19.22% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
